USPTO serial 79363829
LIFE FORWARD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 4, 2025
- Examiner
- TANNER, MICHAEL R
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LIFE FORWARD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boehringer Ingelheim International GmbH
DE
Other trademarks owned by Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH
DE
Other trademarks owned by Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH
DE
Other trademarks owned by Boehringer Ingelheim International GmbH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; biochemical preparations for use in industry and science, namely, biochemical reagents for scientific and research use, proteins for use in the manufacture of pharmaceuticals, proteins for scientific and medical research use; biological preparations for use in industry and science | ACTIVE | — |
| 003 | Cosmetics for animals; animal grooming preparations, namely, non-medicated shampoos for animals, non-medicated pet shampoos | ACTIVE | — |
| 005 | Pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system, pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders, pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders, pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders, pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; stem-cells for medical purposes; biological tissue cultures for medical purposes; antibodies for medical purposes; vaccines; dietary supplements; dietetic preparations, namely dietetic foods and beverages adapted for medical use; veterinary preparations, namely, veterinary pharmaceutical preparations for the prevention and the treatment of metabolic diseases, veterinary pharmaceutical preparations for the prevention and the treatment of cardiovascular diseases, veterinary pharmaceutical preparations for the prevention and the treatment of neurological diseases and disorders, veterinary pharmaceutical preparations for the prevention and the treatment of musculoskeletal diseases and disorders, veterinary pharmaceutical preparations for the prevention and treatment of tendon and muscle damage and injuries, veterinary pharmaceutical preparations for the prevention and the treatment of hormonal diseases and disorders, veterinary pharmaceutical preparations against bacterial infections, namely, antibiotics, anti-infectives, veterinary pharmaceutical preparations for the prevention and the treatment of respiratory diseases, veterinary pharmaceutical preparations for the treatment of inflammatory diseases, veterinary pharmaceutical preparations for udder care, sedatives for animals; stem- cells for veterinary purposes; biological tissue cultures for veterinary purposes; veterinary vaccines; antiparasitics; dietary supplements for veterinary use; dietetic preparations for veterinary use, namely, dietetic foods and beverages adapted for veterinary use, dietetic pet foods adapted for veterinary purposes | ACTIVE | — |
| 009 | Recorded or downloadable computer software for use in database management in the healthcare field; Downloadable software in the nature of a mobile application for the collection, editing, organizing, modifying, transmission, storage, and sharing of data and information in the veterinary and medical field; downloadable mobile applications for creating, developing and providing personalized therapeutic recommendations associated with a defined set of symptoms for physicians and healthcare practitioners used to support clinical decision-making; downloadable mobile applications for use accessing healthcare information for the purpose of receiving personalized healthcare services and healthcare information; downloadable software as a medical device (SaMD) for treating mental health disorders and diseases of the central nervous system; downloadable Software as a Medical Device (SaMD) for use as a medical instrument for auscultation and for recording and transmission of body sounds made by internal organs for diagnostic purposes | ACTIVE | — |
| 010 | Surgical, medical, dental apparatus and instruments, namely, medical imaging apparatus; medical apparatus for auscultation and for recording and transmission of body sounds made by internal organs for diagnostic purposes; veterinary apparatus and instruments, namely, surgical apparatus and instruments for veterinary use, Surgical apparatus and instruments for medical use; inhalation devices, namely, inhalers for medical purposes sold empty, medical apparatus for facilitating the inhalation of pharmaceutical preparations; injectors for medical purposes, namely, medical fluid injectors, syringes for injections, injection instruments without needles | ACTIVE | — |
| 031 | Foodstuffs for animals | ACTIVE | — |
| 041 | Educational services, namely, medical training and teaching, providing live and on-line education seminars in the medical and veterinary field, providing educational workshops in the medical and veterinary field; publishing of books, journals, and other publication on communication media in the medical, veterinary and pharmaceutical fields, namely, online electronic publishing of books and periodicals in the medical, veterinary and pharmaceutical fields; publication of texts, books, and journals in the medical, veterinary and pharmaceutical fields; Providing non-downloadable podcasts in the medical and veterinary field; publishing of journals, books and handbooks in the field of medicine; arranging and conducting of congresses and seminars in the medical, veterinary and pharmaceutical field; organization of exhibitions in the medical, veterinary and pharmaceutical fields for cultural or educational purposes | ACTIVE | — |
| 042 | Medical, veterinary, pharmacological, biological and scientific research; conducting clinical trials for others; computer programming for others in the medical and veterinary field; design and development of computer software for others for use with medical technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Boehringer Ingelheim International GmbH
- Other trademarks owned by Boehringer Ingelheim International GmbH
- Other trademarks owned by Boehringer Ingelheim International GmbH
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 031
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named LIFE FORWARD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 3, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 15, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 15, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 4, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 4, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 4, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 6, 2025 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Aug 21, 2024 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 11, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 30, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 30, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 22, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 21, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 10, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 26, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 29, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 29, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 29, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 29, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 7, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 7, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 7, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 17, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 25, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 25, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 7, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 6, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 31, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 3, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 24, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |